Yingchun Xu Selected Research

Nucleic Acids

1/2022

SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingchun Xu Research Topics

Disease

29	Infections 12/2022 - 06/2010
25	Neoplasms (Cancer) 01/2022 - 01/2011
15	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2011
10	Intraabdominal Infections 01/2021 - 06/2010
9	COVID-19 01/2022 - 01/2020
6	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2017
5	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 09/2018
5	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 11/2011
5	Fever (Fevers) 05/2020 - 09/2015
4	Inflammation (Inflammations) 12/2021 - 11/2020
4	Pneumonia (Pneumonitis) 10/2020 - 10/2015
3	Abscess 08/2021 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 04/2011
2	Melanoma (Melanoma, Malignant) 10/2021 - 03/2020
2	Liver Abscess 01/2021 - 01/2020
2	Rheumatic Diseases (Rheumatism) 01/2021 - 12/2016
2	Hemorrhage 01/2021 - 04/2020
2	Meningitis 01/2021 - 10/2016
2	Coinfection 04/2020 - 11/2018
2	Opportunistic Infections (Opportunistic Infection) 01/2020 - 10/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 12/2016
2	Encephalitis (Encephalitis, Rasmussen) 12/2019 - 01/2018
2	Febrile Seizures (Febrile Seizure) 12/2019 - 01/2018
2	Hepatitis B 11/2019 - 03/2016
2	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 10/2016
2	Wounds and Injuries (Trauma) 12/2016 - 11/2016
2	Sepsis (Septicemia) 02/2016 - 12/2002
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2011
2	Lung Neoplasms (Lung Cancer) 01/2016 - 04/2011
1	Pneumococcal Infections 01/2022
1	Lymphopenia (Lymphocytopenia) 02/2021

Drug/Important Bio-Agent (IBA)

17	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2010
10	Carbapenems (Carbapenem Antibiotics)IBA 12/2022 - 06/2012
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2016
8	Pharmaceutical PreparationsIBA 01/2021 - 11/2016
8	CytokinesIBA 11/2020 - 10/2015
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2014
5	Biological ProductsIBA 01/2022 - 11/2015
4	AntibodiesIBA 01/2022 - 06/2019
4	AntigensIBA 09/2021 - 02/2017
4	Imipenem FDA Link 08/2021 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 02/2021 - 10/2015
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 11/2018
4	RNA (Ribonucleic Acid)IBA 03/2020 - 03/2017
3	Indicators and Reagents (Reagents)IBA 12/2021 - 10/2002
3	Amikacin (A.M.K)FDA LinkGeneric 08/2021 - 06/2012
3	Anti-Infective Agents (Microbicides)IBA 01/2021 - 11/2011
3	Peptides (Polypeptides)IBA 01/2021 - 05/2014
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
3	beta-Lactamases (beta-Lactamase)IBA 01/2021 - 12/2002
3	Immunoglobulin G (IgG)IBA 12/2020 - 06/2019
3	Antiphospholipid AntibodiesIBA 12/2020 - 01/2020
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 02/2017
3	Interleukin-8 (Interleukin 8)IBA 12/2019 - 10/2015
3	Hormones (Hormone)IBA 02/2019 - 10/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 11/2018 - 03/2017
3	Estrogen ReceptorsIBA 11/2018 - 03/2017
2	Colistin (Coly-Mycin)FDA Link 12/2022 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2017
2	Penicillins (Penicillin)FDA Link 01/2022 - 01/2021
2	sortase AIBA 09/2021 - 02/2017
2	Ertapenem (Invanz)FDA Link 08/2021 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 01/2017
2	relebactamIBA 01/2021 - 12/2020
2	Immunoglobulin A (IgA)IBA 12/2020 - 04/2020
2	Ceftaroline FDA Link 10/2020 - 11/2018
2	ceftazidime drug combination avibactamIBA 10/2020 - 11/2018
2	Interleukin-2 (IL2)IBA 04/2020 - 10/2015
2	ChemokinesIBA 03/2020 - 01/2018
2	LigandsIBA 01/2020 - 02/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 10/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 12/2019 - 10/2015
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 11/2018
2	TOR Serine-Threonine KinasesIBA 08/2018 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 03/2017 - 03/2016
2	Messenger RNA (mRNA)IBA 03/2017 - 10/2016
2	SuspensionsIBA 01/2017 - 09/2011
2	SteroidsIBA 12/2016 - 10/2015
2	flomoxefIBA 05/2015 - 04/2015
1	Monoclonal AntibodiesIBA 01/2022
1	Contrast MediaIBA 01/2022
1	LactamsIBA 01/2022
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	ThrombomodulinIBA 12/2021
1	Syndecan-1 (Syndecan 1)IBA 12/2021
1	DNA VaccinesIBA 10/2021
1	Bispecific AntibodiesIBA 09/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 08/2021
1	AlbuminsIBA 02/2021
1	fibrin fragment D (D-dimer)IBA 02/2021

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2011
5	Immunotherapy 01/2022 - 01/2019
2	Precision Medicine 11/2020 - 03/2020
2	Length of Stay 05/2020 - 06/2010
2	Drug Therapy (Chemotherapy) 01/2020 - 11/2015
1	Glycemic Control 01/2021